CONMED CORPORATION Revenue, Net (Deprecated 2018-01-31)
CONMED CORPORATION (CNMD) reported Revenue, Net (Deprecated 2018-01-31) of $212.82 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-08-02
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $212.82M, a 7.95% increase year-over-year.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $202.06M, a 8.31% increase year-over-year.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $222.56M, a 9.05% increase year-over-year.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $190.12M, a 2.88% increase year-over-year.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for fiscal 2017 was $796.39M, a 4.31% increase from fiscal 2016.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for fiscal 2016 was $763.52M, a 6.17% increase from fiscal 2015.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for fiscal 2015 was $719.17M, a 2.82% decline from fiscal 2014.
- CONMED CORPORATION revenue, net (deprecated 2018-01-31) for fiscal 2014 was $740.05M, a 2.97% decline from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $212.82M 10-Q · filed 2018-08-02 | $414.88M 10-Q · filed 2018-08-02 | $637.44M derived: sum of 3 quarters · filed 2018-08-02 | $827.56M derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | $202.06M 10-Q · filed 2018-04-26 | $424.62M derived: sum of 2 quarters · filed 2018-04-26 | $614.74M derived: sum of 3 quarters · filed 2018-04-26 | $811.89M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-12-31 | $222.56M 10-K · filed 2018-02-26 | $412.67M derived: sum of 2 quarters · filed 2018-02-26 | $609.83M derived: sum of 3 quarters · filed 2018-08-02 | $796.39M 10-K · filed 2018-02-26 |
| 2017-09-30 | $190.12M 10-K · filed 2018-02-26 | $387.27M derived: sum of 2 quarters · filed 2018-08-02 | $573.84M 10-Q · filed 2017-11-02 | $777.93M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-06-30 | $197.15M 10-Q · filed 2018-08-02 | $383.72M 10-Q · filed 2018-08-02 | $587.82M derived: sum of 3 quarters · filed 2018-08-02 | $772.61M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $186.57M 10-Q · filed 2018-04-26 | $390.66M derived: sum of 2 quarters · filed 2018-04-26 | $575.45M derived: sum of 3 quarters · filed 2018-04-26 | $768.89M derived: sum of 4 quarters · filed 2018-04-26 |
| 2016-12-31 | $204.09M 10-K · filed 2018-02-26 | $388.89M derived: sum of 2 quarters · filed 2018-02-26 | $582.32M derived: sum of 3 quarters · filed 2018-02-26 | $763.52M 10-K · filed 2018-02-26 |
| 2016-09-30 | $184.79M 10-K · filed 2018-02-26 | $378.23M derived: sum of 2 quarters · filed 2018-02-26 | $559.43M 10-Q · filed 2017-11-02 | $750.44M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $193.43M 10-K · filed 2018-02-26 | $374.63M 10-Q · filed 2017-07-27 | $565.65M derived: sum of 3 quarters · filed 2018-02-26 | $734.84M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $181.20M 10-K · filed 2018-02-26 | $372.22M derived: sum of 2 quarters · filed 2018-02-26 | $541.40M derived: sum of 3 quarters · filed 2018-02-26 | $722.43M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $191.02M 10-K · filed 2017-02-27 | $360.20M derived: sum of 2 quarters · filed 2017-02-27 | $541.23M derived: sum of 3 quarters · filed 2017-02-27 | $719.17M 10-K · filed 2018-02-26 |
| 2015-09-30 | $169.18M 10-K · filed 2017-02-27 | $350.21M derived: sum of 2 quarters · filed 2017-02-27 | $528.15M 10-Q · filed 2016-10-28 | $723.15M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $181.03M 10-K · filed 2017-02-27 | $358.97M 10-Q · filed 2016-07-28 | $553.97M derived: sum of 3 quarters · filed 2017-02-27 | $728.93M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $177.94M 10-K · filed 2017-02-27 | $372.94M derived: sum of 2 quarters · filed 2017-02-27 | $547.90M derived: sum of 3 quarters · filed 2017-02-27 | $736.05M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $195.00M 10-K · filed 2016-02-23 | $369.96M derived: sum of 2 quarters · filed 2016-02-23 | $558.11M derived: sum of 3 quarters · filed 2016-02-23 | $740.05M 10-K · filed 2017-02-27 |
| 2014-09-30 | $174.96M 10-K · filed 2016-02-23 | $363.11M derived: sum of 2 quarters · filed 2016-02-23 | $545.05M 10-Q · filed 2015-10-23 | $748.49M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $188.15M 10-K · filed 2016-02-23 | $370.09M 10-Q · filed 2015-07-27 | $573.53M derived: sum of 3 quarters · filed 2016-02-23 | $752.79M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $181.94M 10-K · filed 2016-02-23 | $385.38M derived: sum of 2 quarters · filed 2016-02-23 | $564.64M derived: sum of 3 quarters · filed 2016-02-23 | $757.63M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $203.44M 10-K · filed 2015-02-23 | $382.70M derived: sum of 2 quarters · filed 2015-02-23 | $575.69M derived: sum of 3 quarters · filed 2015-02-23 | $762.70M 10-K · filed 2016-02-23 |
| 2013-09-30 | $179.25M 10-K · filed 2015-02-23 | $372.25M derived: sum of 2 quarters · filed 2015-02-23 | $559.26M 10-Q · filed 2014-10-24 | $760.51M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $192.99M 10-K · filed 2015-02-23 | $380.01M 10-Q · filed 2014-07-25 | $581.25M derived: sum of 3 quarters · filed 2015-02-23 | $763.14M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $187.01M 10-K · filed 2015-02-23 | $388.26M derived: sum of 2 quarters · filed 2015-02-23 | $570.14M derived: sum of 3 quarters · filed 2015-02-23 | $759.84M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $201.24M 10-K · filed 2014-02-24 | $383.13M derived: sum of 2 quarters · filed 2014-02-24 | $572.82M derived: sum of 3 quarters · filed 2014-02-24 | $767.14M 10-K · filed 2015-02-23 |
| 2012-09-30 | $181.88M 10-K · filed 2014-02-24 | $371.58M derived: sum of 2 quarters · filed 2014-02-24 | $565.90M 10-Q · filed 2013-10-28 | $751.47M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $189.69M 10-K · filed 2014-02-24 | $384.01M 10-Q · filed 2013-07-29 | $569.59M derived: sum of 3 quarters · filed 2014-02-24 | $742.40M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $194.32M 10-K · filed 2014-02-24 | $379.89M derived: sum of 2 quarters · filed 2014-02-24 | $552.71M derived: sum of 3 quarters · filed 2014-02-24 | $735.94M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $185.58M 10-K · filed 2013-02-25 | $358.39M derived: sum of 2 quarters · filed 2013-02-25 | $541.63M derived: sum of 3 quarters · filed 2013-02-25 | $725.08M 10-K · filed 2014-02-24 |
| 2011-09-30 | $172.81M 10-K · filed 2013-02-25 | $356.05M derived: sum of 2 quarters · filed 2013-02-25 | $539.50M 10-Q · filed 2012-10-29 | $723.58M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $183.24M 10-K · filed 2013-02-25 | $366.69M 10-Q · filed 2012-07-30 | $550.76M derived: sum of 3 quarters · filed 2013-02-25 | $722.96M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $183.45M 10-K · filed 2013-02-25 | $367.53M derived: sum of 2 quarters · filed 2013-02-25 | $539.72M derived: sum of 3 quarters · filed 2013-02-25 | $720.81M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $184.08M 10-K · filed 2012-02-28 | $356.27M derived: sum of 2 quarters · filed 2012-02-28 | $537.36M derived: sum of 3 quarters · filed 2012-02-28 | $713.72M 10-K · filed 2013-02-25 |
| 2010-09-30 | $172.19M 10-K · filed 2012-02-28 | $353.28M derived: sum of 2 quarters · filed 2012-02-28 | $529.65M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $181.09M 10-K · filed 2012-02-28 | $357.45M 10-Q · filed 2011-08-09 | ||
| 2010-03-30 | $176.37M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $694.74M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |